• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

X连锁无丙种球蛋白血症与X连锁免疫缺陷基因的共定位。

Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.

作者信息

Thomas J D, Sideras P, Smith C I, Vorechovský I, Chapman V, Paul W E

机构信息

Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

出版信息

Science. 1993 Jul 16;261(5119):355-8. doi: 10.1126/science.8332900.

DOI:10.1126/science.8332900
PMID:8332900
Abstract

Mice that bear the X-linked immunodeficiency (xid) mutation have a B lymphocyte-specific defect resulting in an inability to make antibody responses to polysaccharide antigens. A backcross of 1114 progeny revealed the colocalization of xid with Bruton's agammaglobulinemia tyrosine kinase (btk) gene, which is implicated in the human immune deficiency, X-linked agammaglobulinemia. Mice that carry xid have a missense mutation that alters a highly conserved arginine near the amino-terminus of the btk protein, Btk. Because this region of Btk lies outside any obvious kinase domain, the xid mutation may define another aspect of tyrosine kinase function.

摘要

携带X连锁免疫缺陷(xid)突变的小鼠存在B淋巴细胞特异性缺陷,导致无法对多糖抗原产生抗体反应。对1114只后代进行的回交显示,xid与布鲁顿无丙种球蛋白血症酪氨酸激酶(btk)基因共定位,该基因与人类免疫缺陷疾病X连锁无丙种球蛋白血症有关。携带xid的小鼠存在一个错义突变,该突变改变了btk蛋白(Btk)氨基末端附近一个高度保守的精氨酸。由于Btk的这一区域位于任何明显的激酶结构域之外,xid突变可能定义了酪氨酸激酶功能的另一个方面。

相似文献

1
Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.X连锁无丙种球蛋白血症与X连锁免疫缺陷基因的共定位。
Science. 1993 Jul 16;261(5119):355-8. doi: 10.1126/science.8332900.
2
Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.免疫缺陷XID小鼠中布鲁顿酪氨酸激酶独特区域的突变
Science. 1993 Jul 16;261(5119):358-61. doi: 10.1126/science.8332901.
3
Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.X连锁无丙种球蛋白血症中布鲁顿酪氨酸激酶基因的突变分析:鉴定出一个与免疫缺陷xid小鼠中发生改变的密码子相同的突变。
Hum Mol Genet. 1994 Jan;3(1):161-6. doi: 10.1093/hmg/3.1.161.
4
Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.布鲁顿酪氨酸激酶:细胞生物学、序列保守性、突变谱、小干扰RNA修饰及表达谱分析
Immunol Rev. 2005 Feb;203:200-15. doi: 10.1111/j.0105-2896.2005.00225.x.
5
Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.布鲁顿酪氨酸激酶是B细胞受体激活时,激活IκB激酶和核因子κB所必需的。
J Exp Med. 2000 May 15;191(10):1745-54. doi: 10.1084/jem.191.10.1745.
6
Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity.布鲁顿酪氨酸激酶的普列克底物蛋白同源结构域突变导致免疫缺陷,损害了肌醇1,3,4,5-四磷酸结合能力。
J Biol Chem. 1996 Nov 29;271(48):30303-6. doi: 10.1074/jbc.271.48.30303.
7
xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.Xid小鼠揭示了B细胞发育多个阶段中稳态与布鲁顿酪氨酸激酶介导的选择之间的相互作用。
Int Immunol. 2001 Dec;13(12):1501-14. doi: 10.1093/intimm/13.12.1501.
8
Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.35个X连锁无丙种球蛋白血症家族中布鲁顿酪氨酸激酶(Btk)基因突变的鉴定及衍生蛋白的特征分析:日本全国性Btk缺乏症研究
Blood. 1996 Jul 15;88(2):561-73.
9
Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).布鲁顿酪氨酸激酶的Src同源结构域3内的缺失导致X连锁无丙种球蛋白血症(XLA)。
J Exp Med. 1994 Aug 1;180(2):461-70. doi: 10.1084/jem.180.2.461.
10
Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation.追踪体内Xid B细胞的反应:TI-2抗原诱导迁移和增殖,但Btk对终末分化至关重要。
Eur J Immunol. 2001 May;31(5):1340-50. doi: 10.1002/1521-4141(200105)31:5<1340::AID-IMMU1340>3.0.CO;2-H.

引用本文的文献

1
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in / double deficient X-linked agammaglobulinemia model.细胞穿透肽偶联的剪接转换寡核苷酸减轻X连锁无丙种球蛋白血症双缺陷模型中的表型。
RSC Chem Biol. 2025 Mar 31;6(5):761-771. doi: 10.1039/d4cb00312h. eCollection 2025 May 8.
2
Btk inhibition: the importance of being selective.布鲁顿酪氨酸激酶(Btk)抑制:选择性的重要性
Blood Adv. 2024 Nov 12;8(21):5579-5580. doi: 10.1182/bloodadvances.2024014009.
3
Inborn Errors of Immunity and Cytokine Storm Syndromes.
先天性免疫缺陷和细胞因子风暴综合征。
Adv Exp Med Biol. 2024;1448:185-207. doi: 10.1007/978-3-031-59815-9_14.
4
Bruton's tyrosine kinase inhibition limits endotoxic shock by suppressing IL-6 production by marginal zone B cells in mice.布鲁顿酪氨酸激酶抑制通过抑制边缘区 B 细胞产生白细胞介素 6 来限制内毒素休克。
Front Immunol. 2024 Apr 4;15:1388947. doi: 10.3389/fimmu.2024.1388947. eCollection 2024.
5
In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function.在布鲁顿酪氨酸激酶(BTK)中,SH3结构域中的磷酸化Y223反映催化活性,但不影响生物学功能。
Blood Adv. 2024 Apr 23;8(8):1981-1990. doi: 10.1182/bloodadvances.2024012706.
6
BTK inhibitors in CLL: second-generation drugs and beyond.慢性淋巴细胞白血病中的 BTK 抑制剂:第二代药物及其他。
Blood Adv. 2024 May 14;8(9):2300-2309. doi: 10.1182/bloodadvances.2023012221.
7
Bruton tyrosine kinase inhibitors for multiple sclerosis.用于多发性硬化症的布鲁顿酪氨酸激酶抑制剂。
Nat Rev Neurol. 2023 May;19(5):289-304. doi: 10.1038/s41582-023-00800-7. Epub 2023 Apr 13.
8
BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies.BTK 抑制剂在血液系统恶性肿瘤和炎症性疾病治疗中的作用机制及临床研究。
J Hematol Oncol. 2022 Oct 1;15(1):138. doi: 10.1186/s13045-022-01353-w.
9
Estimating the number of diseases - the concept of rare, ultra-rare, and hyper-rare.疾病数量的估算——罕见、超罕见和极度罕见的概念。
iScience. 2022 Jul 1;25(8):104698. doi: 10.1016/j.isci.2022.104698. eCollection 2022 Aug 19.
10
Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia.新型2,6,9-三取代嘌呤衍生物作为潜在抗白血病药物的设计、合成、计算机模拟研究及其对Bcr-Abl、BTK和FLT3-ITD的抑制活性
Pharmaceutics. 2022 Jun 17;14(6):1294. doi: 10.3390/pharmaceutics14061294.